絞り込み

16643

広告

1348件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.

Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation.

How minimally interrupted direct oral anticoagulants affect intraprocedural anticoagulation during atrial fibrillation ablation? Insights from a Japanese single-center retrospective study.

Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.

Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients.

Prospective comparison of periprocedural coagulation markers among uninterrupted anticoagulants for atrial fibrillation ablation.

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.

Drugs for atrial fibrillation.

Treatment Failures of Direct Oral Anticoagulants.

Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.

New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.

Treatment of pulmonary thromboembolism with edoxaban in a cancer patient with borderline fulfillment of the dose reduction criteria.

The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants.

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI.

Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs.

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7).

Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.

Total costs of treating venous thromboembolism: implication of different cost perspectives in a Danish setting.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります